Author:
Glotz Denis,Chapman Jeremy R.,Dharnidharka Vikas R.,Hanto Douglas W.,Castro Maria C.R.,Hirsch Hans H.,Leblond Véronique,Mehta Aneesh K.,Moulin Bruno,Pagliuca Antonio,Pascual Julio,Rickinson Alan B.,Russo Francesco P.,Trappe Ralf U.,Webster Angela C.,Zuckermann Andreas O.,Gross Thomas G.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference79 articles.
1. Ziarkiewicz-Wroblewska B, et al..;Mucha;Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease Nephrol Dial Transplant,2010
2. . Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment.;Allen;Can J Infect Dis,2002
3. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplant Recipients.;Allen;Am J Transplant,2009
4. . Pretransplantation assessment of the risk of lymphoproliferative disorder.;Walker;Clin Infect Dis,1995
5. . Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.;Trappe;Lancet Oncol,2012
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献